VIR · Vir Biotechnology Inc
United States · RS rating 87 · As of 2026-11-03
| Price | 11.22 USD |
|---|---|
| 1-day change | +2.0% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 45 / 91 / 93 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 59 / 73 / 66 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +73.5% |
| Sales growth Q/Q | +98192.3% |
| Distance from 52-week high | +6.0% |
| Market cap (USD) | $1.7B |